A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Public ClinicalTrials.gov record NCT06958536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR442970 in Adults With Moderate to Severe Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up to 168 weeks, with a treatment period of up to 158 weeks including an open-label (OL) long-term extension (LTE) period of up to 104 weeks for eligible participants.
Study identification
- NCT ID
- NCT06958536
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2, 2025
- Primary completion
- Dec 16, 2026
- Completion
- Oct 16, 2029
- Last update posted
- Mar 26, 2026
2025 – 2029
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number: 8400024 | Tucson | Arizona | 85724 | Recruiting |
| Investigational Site Number: 8400005 | Escondido | California | 92025 | Recruiting |
| Investigational Site Number: 8400001 | Lancaster | California | 93534 | Recruiting |
| Investigational Site Number: 8400017 | Kissimmee | Florida | 34741 | Recruiting |
| Investigational Site Number: 8400015 | Lighthouse PT | Florida | 33064 | Recruiting |
| Investigational Site Number 8400028 | Miami | Florida | 33134 | Recruiting |
| Investigational Site Number: 8400012 | Miami | Florida | 33136 | Recruiting |
| Investigational Site Number: 8400007 | Orlando | Florida | 32804 | Recruiting |
| Investigational Site Number: 8400011 | Palmetto Bay | Florida | 33176 | Recruiting |
| Investigational Site Number: 8400019 | Marietta | Georgia | 30060 | Recruiting |
| Investigational Site Number: 8400025 | Iowa City | Iowa | 52242 | Recruiting |
| Investigational Site Number: 8400006 | Kansas City | Kansas | 66160 | Recruiting |
| Investigational Site Number: 8400022 | Boston | Massachusetts | 02115 | Recruiting |
| Investigational Site Number: 8400008 | Wyoming | Michigan | 49519 | Recruiting |
| Investigational Site Number: 8400013 | St Louis | Missouri | 63110 | Recruiting |
| Investigational Site Number: 8400003 | Chapel Hill | North Carolina | 27599 | Recruiting |
| Investigational Site Number: 8400009 | Harrisburg | Pennsylvania | 17110 | Recruiting |
| Investigational Site Number: 8400002 | Fredericksburg | Texas | 78229 | Recruiting |
| Investigational Site Number: 8400016 | Ogden | Utah | 84405 | Recruiting |
| Investigational Site Number: 8400027 | Richmond | Virginia | 23249 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06958536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06958536 live on ClinicalTrials.gov.